PREZCOBIX (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the PREZCOBIX drug offered from REMEDYREPACK INC.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
| NON-PROPRIETARY NAME: | DARUNAVIR ETHANOLATE and COBICISTAT |
| SUBSTANCE NAME: | DARUNAVIR ETHANOLATE; COBICISTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-08-28 |
| END MARKETING DATE: | 0000-00-00 |
PREZCOBIX HUMAN PRESCRIPTION DRUG Details:
| Item Description | PREZCOBIX from REMEDYREPACK INC. |
| LABELER NAME: | REMEDYREPACK INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 800; 150(mg/1; mg/1) |
| START MARKETING DATE: | 2017-08-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70518-0714_57d659cd-7602-7b3e-e053-2991aa0a162d |
| PRODUCT NDC: | 70518-0714 |
| APPLICATION NUMBER: | NDA205395 |
Other DARUNAVIR ETHANOLATE; COBICISTAT Pharmaceutical Manufacturers / Labelers:
